Publications & Works

Publication Network
Articles 21
All (21)
SCI-E, SSCI, AHCI (18)
SCI-E, SSCI, AHCI, ESCI (19)
ESCI (1)
Scopus (19)
TRDizin (7)

1. Deserved or Undeserved? Paranoia Subtypes as Predictors of Internalized Stigma in Schizophrenia

Doğan A., Çakmak I. B., Bal N. B., KIR Y., BASKAK B.
Psychiatry and Clinical Psychopharmacology , vol.36, no.1, pp.30-38, 2026 (SCI-Expanded, Scopus, TRDizin)

2. The Psychiatric Association of Türkiye Depression Treatment Guidelines-I: Introduction, Terminology, Core Concepts, Assessment Methods

Ozturk E. O., Tatli S. Z., Bucgun I., Ceylan D., ÇELİK H. E., EKER M. Ç., et al.
TURK PSIKIYATRI DERGISI , vol.36, pp.586-594, 2025 (SSCI, Scopus) Sustainable Development

3. Analysis of functional connectivity differences in Schizophrenia groups characterized by M1 receptor polymorphism during the N-Back task with fNIRS

ÇAĞLAYAN E., KIR Y., ÇAKIR M. P., BASKAK B.
Psychiatry Research - Neuroimaging , vol.352, 2025 (SCI-Expanded, Scopus)

4. Hashimoto's encephalopathy in psychiatric inpatients: neuropsychiatric morbidity, diagnostic challenges and treatment

İlhan R. S., Can K. C., Yalçın Şahiner Ş., Duman B., Çolak B., Kır Y., et al.
FRONTIERS IN PSYCHIATRY , vol.16, 2025 (SCI-Expanded, SSCI, Scopus)

5. The effects of UGT1A4 and ABCB1 polymorphisms on clozapine and Ndesmethyl clozapine plasma levels in Turkish schizophrenia patients

Ozdemir F., Oz M. D., Tok K. C., Dural E., Kır Y., Gumustas M., et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY , vol.495, 2025 (SCI-Expanded, Scopus)

6. Assessment of Genetic and Lifestyle Factors on Clozapine and N-desmethylclozapine Plasma Levels in Schizophrenia Patients

Demirbügen Öz M., Özdemir F., Tok K. C., Dural E., Kır Y., Ulusoy M., et al.
PHARMACOPSYCHIATRY CLINICAL PHARMACOLOGY, PSYCHIATRY, PSYCHOLOGY, NEUROPHYSIOLOGY, NEUROBIOLOGY, GERONTOPSYCHIATRY , vol.57, no.2, pp.87, 2024 (SCI-Expanded, Scopus) Sustainable Development

7. The Potential Role of POR*28 and CYP1A2*F Genetic Variations and Lifestyle Factors on Clozapine and N-DesmethylClozapine Plasma Levels in Schizophrenia Patients

Demirbügen Öz M., Ozdemir F., Tok K. C., Dural E., Kir Y., Ulusoy M., et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY , vol.19, no.5, pp.319-327, 2023 (SCI-Expanded) Sustainable Development

8. Attachment Security and Cortical Activity Measured by Functional Near-Infrared Spectroscopy During a Working Memory Task in Healthy Young Adults

Kuşman A., Kir Y., Baskak N. S., Akaslan D. S., Yalçinkaya B., CENGİZ E. G., et al.
Noropsikiyatri Arsivi , vol.60, no.3, pp.214-222, 2023 (SCI-Expanded, Scopus, TRDizin)

9. Effects of family functions on Opioid Use Disorder patients to remission

Sahiner I. V., Ucan Y., Sahiner Ş.
HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS , vol.24, no.1, pp.39-45, 2022 (SSCI, Scopus) Sustainable Development

10. Long Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Bipolar Disorder.

DEVRİMCİ ÖZGÜVEN H., KIR Y.
NOROPSIKIYATRI ARSIVI , vol.58, 2021 (SCI-Expanded, Scopus, TRDizin)

11. Cortical activity measured by functional near infrared spectroscopy during a theory of mind task in subjects with schizophrenia, bipolar disorder and healthy controls

Sayar-Akaslan D., BASKAK B., Kir Y., Kusman A., Yalcinkaya B., Cakmak I. B., et al.
JOURNAL OF AFFECTIVE DISORDERS , pp.329-339, 2021 (SCI-Expanded, SSCI, Scopus) Sustainable Development

12. Cortical activity during social acceptance and rejection task in social anxiety disorder: A controlled functional near infrared spectroscopy study

Kir Y., Sayar-Akaslan D., Agtas-Ertan E., Kusman A., Baskak N., BARAN Z., et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY , 2021 (SCI-Expanded, SSCI, Scopus)

13. A Novel Genotyping Method for Detection of Muscarinic Receptor M1 Gene rs2067477 Polymorphism and Its Genotype/Allele Frequencies in a Turkish Population

ÖZDEMİR F., KIR Y., TOK K. C., BASKAK B., SÜZEN H. S.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.17, no.6, pp.653-658, 2020 (ESCI, Scopus, TRDizin)

14. The Association of Minor Physical Anomalies with Clinical and Subclinical Psychotic Symptoms

KUŞMAN A., YALÇINKAYA KARANLIK B., KIR Y., AKSOY U. M., Özdemir B. N., dilek z. g., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.73, 2020 (TRDizin)

15. The relationship between plasma levels of clozapine and N-desmethyclozapine as well as M1 receptor polymorphism with cognitive functioning and associated cortical activity in schizophrenia

Kir Y., BASKAK B., Kusman A., Sayar-Akaslan D., Ozdemir F., Sedes-Baskak N., et al.
PSYCHIATRY RESEARCH-NEUROIMAGING , 2020 (SCI-Expanded, SSCI, Scopus) Sustainable Development

16. Investigation of the Cortical Activity During Episodic Future Thinking in Schizophrenia: A Functional Near-Infrared Spectroscopy Study

Gunduz H., BARAN Z., Kir Y., Baskak N. S., Baskak B.
BEHAVIORAL NEUROSCIENCE , no.4, pp.344-357, 2020 (SCI-Expanded, SSCI, Scopus) Sustainable Development

17. Attachment Style Predicts Cortical Activity in Temporoparietal Junction (TPJ) An fNIRS Study Using a Theory of Mind (ToM) Task in Healthy University Students

BASKAK B., Kir Y., Sedes N., Kusman A., Turk E. G., BARAN Z., et al.
JOURNAL OF PSYCHOPHYSIOLOGY , no.2, pp.99-109, 2020 (SCI-Expanded, SSCI, Scopus) Sustainable Development

18. Determination of Mirtazapine and Desmethyl Mirtazapine in Human Plasma by a New Validated HPLC Ultraviolet Method with a Simple and Reliable Extraction Method: Application to Therapeutic Drug Monitoring Study by 62 Real Patient Plasma

DURAL E., Baskak N. S., Ozcan H., Kir Y., BASKAK B., SÜZEN H. S.
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH , no.1, pp.18-30, 2020 (SCI-Expanded, Scopus) Sustainable Development

19. The Association of CYP2D6*4 and POR*28 Polymorphisms on Mirtazapine Plasma Level in Subjects with Major Depressive Disorder and Anxiety Disorders

Ozdemir F., DURAL E., Baskak N. S., Kir Y., BASKAK B., Suzen H. S.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING , no.10, pp.1032-1040, 2020 (SCI-Expanded, Scopus) Sustainable Development

20. Prefrontal Cortex Activity During Facial Affect Processing in Schizophrenia: Association with Clinical Symptoms and Social Cognitive Functions

Abdullayev A., BASKAK B., Baskak N. S., Kir Y., Kale E., ÖZGÜVEN H., et al.
TURK PSIKIYATRI DERGISI , no.4, 2018 (SSCI, Scopus, TRDizin) Sustainable Development

21. Person ıdentıfıcatıon usıng functıonal near- ınfrared spectroscopy sıgnals usıng a fully connected deep neural network

MERCANOĞLU Ö., YALIM KELEŞ H., KIR Y., KUSMAN A., BASKAK B.
Communications Faculty of Sciences University of Ankara Series A2-A3: Physical Sciences and Engineering , vol.59, pp.55-67, 2017 (TRDizin)
Papers Presented at Peer-Reviewed Scientific Conferences 10

1. Stuttering associated with clozapine use: a case report

Cihan K. H., Kır Y.
38th ECNP Congress, Amsterdam, Netherlands, 11 - 14 October 2025, vol.5, pp.106747, (Summary Text)

2. A case of reversible dementia: exploring potential autoimmunity and diagnostic challenges

Emri C., İLHAN R. S., CAN K. C., Uzel Y., DUMAN B., ÇOLAK B., et al.
38th ECNP Congress, Amsterdam, Netherlands, 11 October 2025, vol.5, pp.44, (Summary Text)

3. A prodromal frontotemporal dementia presenting with Cotard’s syndrome: neurodegeneration behind a psychotic mask

Özkaya B. G., Uzel Y., İLHAN R. S., Emri C., DUMAN B., ÇOLAK B., et al.
38th ECNP Congress, Amsterdam, Netherlands, 11 October 2025, vol.5, pp.22, (Summary Text)

4. Anti-NDMR encephalitis presenting with catatonia and memory deficits associated with ovarian teratoma in a young female: a multidisciplinary diagnostic challenge

Uzel Y., İLHAN R. S., CAN K. C., Emri C., DUMAN B., ÜNAL S., et al.
38th ECNP Congress, Amsterdam, Netherlands, 11 - 14 October 2025, vol.5, pp.37, (Summary Text)

5. Chronic hyponatremia presenting with cerebellar ataxia masquerading as a functional neurological disorder: a case report

Tosun Ö., Özçelik K., İLHAN R. S., CAN K. C., ÇOLAK B., KIR Y., et al.
38th ECNP Congress, Netherlands, 11 - 14 October 2025, vol.5, pp.46, (Summary Text)

6. Cortical activity during social acceptance and rejection in social anxiety disorder

Baskak B., Kir Y., Akaslan D. S., Ertan E. A., Kusman A., Baskak N. S., et al.
32nd Congress of the European-College-of-Neuropsychopharmacology (ECNP), Copenhagen, Denmark, 7 - 10 September 2019, vol.29, (Summary Text)

7. 5-HT2A rs6311 and rs6313 Polymorphisms With Obsessive-Compulsive Symptoms in Schizophrenia Patients Under Clozapine Monotherapy.

KIR Y., BASKAK B., KUŞMAN A., SAYAR AKASLAN D., SEDES BASKAK N., BARAN Z., et al.
11th International Congress of Psychopharmacology, Antalya, Turkey, 18 - 21 April 2019, (Full Text)

8. Sosyal Anksiyete Bozukluğunda Sosyal Kabul ve Ret Sırasında Ortaya Çıkan Korteks Aktivitesinin İşlevsel Yakın Kızılötesi Spektroskopi ile Değerlendirilmesi.

KIR Y., SAYAR AKASLAN D., AĞTAŞ ERTAN E., BARAN Z., KUŞMAN A., SEDES BASKAK N., et al.
54. Ulusal Psikiyatri Kongresi, Turkey, 2 - 06 October 2018, (Full Text)

9. Bağlanma Biçemi Gözlerden Zihin Okuma Sırasındaki Temporopariyetal Bileşke Aktivitesiyle İlişkilidir.

KIR Y., BASKAK B., SEDES BASKAK N., KUŞMAN A., CENGİZ E. G., BARAN Z., et al.
3 Psikiyatri Zirvesi& 10. Ulusal Anksiyete Kongresi., Turkey, 15 - 18 March 2018, (Full Text)

10. Measurement of visual cortex activity with near infrared spectroscopy after endoscope assisted ARGUS II epiretinal prosthesisimplantation in retinitis pigmentosa patients.

ÖZMERT E., BASKAK B., ARSLANTAŞ R., KIR Y., KUŞMAN A., BARAN Z.
The International Symposium on Visual Prosthetics., Aachen, Germany, 30 December 2017, (Summary Text)
Books 8

1. Approach to Obstetric and Psychiatric Emergencies

Kır Y., Kır E. A.
in: Obstetric and Gynecological Emergencies, Prof. Dr. M. Tamer Mungan, Editor, Modern Tıp Kitabevi, Ankara, pp.657-679, 2025

2. Duygudurum Bozuklukları

Kır Y.
in: Hippocrates Family Medicine, Prof Dr. Serpil Demirağ, Editor, Hipokrat Yayıncılık, Ankara, pp.1151-1163, 2024

3. Nörotransmitter Sistemleri: Biyojenik Aminler.

BASKAK B., KIR Y.
in: Psikofarmakolojinin Temel İlkeleri., ALTINYAZAR VESİLE, YÜKSEL NEVZAT, Editor, Türkiye Psikiyatri Derneği Yayınları, Ankara, pp.39-79, 2022

4. Depresyonun Farmakoterapi ve Diğer Somatik Yöntemlerle Tedavisi.

KIR Y., DEVRİMCİ ÖZGÜVEN H.
in: Depresyon, DEVRİMCİ ÖZGÜVEN HALİSE, Editor, Türkiye Klinikleri;, Ankara, pp.25-44, 2021

5. Cerrahide Psikiyatrik Konular.

KIR Y., AĞTAŞ ERTAN E., DUMAN B., KUMBASAR H.
in: Konsültasyon Liyezon Psikiyatrisi Cilt-2:, ELBİ HAYRİYE, CİMİLLİ HASAN CAN, ÖNEN SERTÖZ ÖZEN, KARŞIDAĞ ÇAĞATAY, SÖZERİ VARMA GÜLFİZAR, Editor, TÜRKİYE PSİKİYATRİ DERNEĞİ YAYINLARI, Ankara, pp.341-350, 2019

6. İntihar Davranışında Nörogörüntüleme Bulguları.

BASKAK B., KIR Y.
in: İntiharı Anlama ve Müdahale Temel Kitap., DEVRİMCİ ÖZGÜVEN HALİSE, SERCAN MUSTAFA, Editor, Türkiye Psikiyatri Derneği Yayınları, Ankara, pp.161-180, 2019

7. İntihar Davranışının Nörobiyolojisi.

DEVRİMCİ ÖZGÜVEN H., KIR Y.
in: İntiharı Anlama ve Müdahale Temel Kitap, DEVRİMCİ ÖZGÜVEN HALİSE, SERCAN MUSTAFA, Editor, Türkiye Psikiyatri Derneği Yayınları, Ankara, pp.134-161, 2019

8. Major Depresif Bozuklukta Bilişsel Disfonksiyonu Değerlendirmek

TANYERİ KAYAHAN S., çalışır i., ŞAHİN S., AKDÖNER B., KIR Y., KUŞMAN A.
in: Cognitive Impairment in Major Depressive Disorder Clinical Relevance, Biological Substrates and Treatment Opportunities.-Major Depresif Bozuklukta Bilişsel Bozulma Klinikle İlişkisi, Biyolojik Altyapıları ve Tedavi İmkanları, Bayram Ece, Editor, Cambridge University Press, pp.256-280, 2018
Metrics

Publication

39

Publication (WoS)

20

Publication (Scopus)

19

Citation (WoS)

54

H-Index (WoS)

5

Citation (Scopus)

59

H-Index (Scopus)

6

Citation (Scholar)

3

H-Index (Scholar)

1

Project

6
UN Sustainable Development Goals
SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING
SDG 5: GOAL 5: GENDER EQUALITY